Elevated CSF dynorphin A [1–8] in Tourette's syndrome
Leckman JF, Riddle MA, Berrettini WH, Anderson GM, Hardin M, Chappell P, Bissette G, Nemeroff CB, Goodman WK, Cohen DJ. Elevated CSF dynorphin A [1–8] in Tourette's syndrome. Life Sciences 1988, 43: 2015-2023. PMID: 2463450, DOI: 10.1016/0024-3205(88)90575-9.Peer-Reviewed Original ResearchConceptsPathobiology of TSTourette syndromeNeuroanatomic distributionEndogenous opioidsNeuropathological studiesObsessive-compulsive disorderPrevalence of TSBehavioral effectsPost-mortem brain studiesPathophysiology of TSGilles de la Tourette's syndromeCentral dopaminergic neuronsRecent neuropathological studiesLevels of dynorphinSevere Tourette syndromeBasal ganglia structuresChronic neuropsychiatric disorderLa Tourette's syndromeCentral monoaminergicCSF dynorphinElevated CSFStriatal fibersCSF studiesDopaminergic neuronsBasal ganglia